Mechanism of Action

 

  • Increases the number and branching of dendrites

  • Enhances neurotransmission by: Inhibiting enzymes (COMT) and preventing the degradation of Catecholamine neurotransmitters / Inhibiting peptidases (PEP) and preventing the degradation of neuropeptides / Enhancing cholinergics and glutaminergic transmission

  • Offers Neuroprotection by inhibiting ROS and PARP

Key Pointers

 
  • Clinically proven to tackle the early symptoms of dementia
  • Clinically proven to be safe for human consumption
  • Clinically validated to improve brain related outcomes in a multi-ethnic population
  • Backed by over 10 scientific publications
  • Compliant to global regulatory standards

Clinical Findings

 
  • 2 published clinical studies including elderly subjects provide evidence that Bacomind® improves memory acquisition and retention, verbal memory and attention.
  • 2 published clinical studies including young children demonstrate that Bacomind® improves learning, memory and cognitive performance
  • Bacomind® is clinically proven to reduce ADHD (Attention Deficit Hyperactivity Disorder) symptoms in Indian children

Indication

Memory Dementia ADHD Cognition

Dosage Forms

  • Tablets

  • Capsules